Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2025-12-24 @ 7:14 PM
NCT ID:
NCT06458803
Eligibility Criteria:
Inclusion Criteria:
1. The patient is diagnosed with CTD, SLE, SS, APS, MCTD, ANCA or RA according to international diagnostic criteria;
2. The patient meets the diagnostic criteria of RITP: (i) glucocorticoid therapy and/or splenectomy is ineffective; (ii) age ≥18 years; (iii) duration of the disease \>6 months; (iv) no other diseases leading to thrombocytopenia; (v) platelet count ≤30×109/L;
3. At the time of enrolment, patients have received ineffective conventional first-line treatment for one year or more;
4. Enrolled patients need to be aware of the clinical information they are being given.
Exclusion Criteria:
1. The patient has a history of lymphoproliferative disease or malignancy of any organ system within the last 5 years;
2. The patient has a combination of other autoimmune diseases or malignant haematological diseases;
3. Patient's intermittent use of medication and failure to take medication as prescribed;
4. Patient refuses to participate in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06458803
Study Brief:
Protocol Section:
NCT06458803